The World Health Organization gave China its support and understanding to start administering experimental coronavirus vaccines to people while clinical trials were still underway, a Chinese health official said on Friday.
China launched its emergency program in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official.
For more coronavirus news, visit our dedicated page.
Hundreds of thousands essential workers and other limited groups of people considered at high risk of infection have been given the vaccine, even though its efficacy and safety had not been fully established as Phase 3 clinical trials were incomplete.
“At end-June, China’s State Council approved a plan of COVID-19 emergency use program,” Zheng told a news conference.
“After the approval, on June 29, we made a communication with the relevant representatives of the WHO Office in China, and obtained support and understanding from WHO,” Zheng said.
For all the latest headlines follow our Google News channel online or via the app
WHO’s representative in China did not immediately respond to a request for comment.
WHO chief scientist Soumya Swaminathan said in Geneva this month that national regulatory authorities could approve use of medical products within their own jurisdictions in the current emergency situation, but described that as a “temporary solution.”
Coronavirus vaccine tested on 90 pct of China’s Sinovac employees, families, says CEO
China’s Sinovac coronavirus vaccine approved for emergency use: Source
Coronavirus: Scientists see downsides to top COVID-19 vaccines from Russia, China
The long-term solution lay in completion of Phase 3 trials, the WHO official said.
Beijing has not publicly released full details of its emergency use program.
At least three vaccination candidates, including two developed by state-backed China National Biotec Group (CNBG) and one from Sinovac Biotech, all in Phase 3 trials overseas, are included in the emergency use program.
A fourth experimental vaccine developed by CanSino Biologics were approved to be used in the Chinese military in June.
Coronavirus: Over 80 pct of people in UK ignore self-isolation rules, study findsOver 80 percent of people in Britain are not adhering to self-isolation guidelines when they have COVID-19 symptoms or had contact with someone who ... Coronavirus
Coronavirus: UAE COVID-19 cases continue to rise with 1,008 new infectionsThe United Arab Emirates reported another significant rise in new coronavirus cases with 1,008 infections detected in 24 hours, the Ministry of Health ... Coronavirus
Coronavirus: Spain’s Madrid extends partial lockdown on over 1 mln peopleMadrid’s regional government expanded the number of areas under partial lockdown Friday in a move now affecting a million people but ignoring a ... Coronavirus
India reports decline in new coronavirus cases with 86,052 infections in 24 hoursIndia reported another 86,052 coronavirus cases in the past 24 hours, a declining trend with recoveries exceeding new cases this week.For more ... Coronavirus
Coronavirus: Scientists see downsides to top COVID-19 vaccines from Russia, ChinaHigh-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people ... Coronavirus
Coronavirus vaccine tested on 90 pct of China’s Sinovac employees, families, says CEOAbout 90 percent of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm ... Coronavirus
China’s Sinovac coronavirus vaccine approved for emergency use: SourceSinovac Biotech Ltd’s coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a program in China to vaccinate high-risk ... Coronavirus